SCHEMBL2184433

SCHEMBL2184433

Cc1ccc(C[C@H]2CCCCO2)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.50
NPSR1 Q6W5P4 2/20 0.50
HPGD P15428 3/20 0.44
ALDH1A1 P00352 5/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
SLC12A2 P55011 1/20 0.43
SLC12A5 Q9H2X9 1/20 0.43
TP53 P04637 2/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
CYP3A4 P08684 2/20 0.41
CYP1A2 P05177 1/20 0.41
TNK2 Q07912 1/20 0.40
TSHR P16473 2/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24763632 1.00 SMN1; SMN2 (0.50) SMN1; SMN2NPSR1HPGDALDH1A1RAB9A
SCHEMBL11242352 0.95 SMN1; SMN2 (0.55) SMN1; SMN2NPSR1HPGDALDH1A1RAB9A
SCHEMBL14097842 0.82 ESR1 (0.43) SMN1; SMN2RAB9ANPC1L3MBTL1TNK2
SCHEMBL15371049 0.82 ALDH1A1 (0.42) SMN1; SMN2HPGDALDH1A1RAB9ANPC1
SCHEMBL1129701 0.82 KMT2A (0.56) SMN1; SMN2HPGDALDH1A1NPC1TNK2
SCHEMBL28263198 0.81 SLC6A2 (0.46) SMN1; SMN2HPGDALDH1A1RAB9ALMNA
SCHEMBL9336828 0.81 HPGD (0.50) SMN1; SMN2HPGDALDH1A1RAB9ANPC1
SCHEMBL11249479 0.80 SLC6A2 (0.45) SMN1; SMN2HPGDALDH1A1RAB9ALMNA
SCHEMBL29307998 0.79 SMN1; SMN2 (0.45) SMN1; SMN2NPSR1HPGDALDH1A1RAB9A
SCHEMBL8024954 0.77 KMT2A (0.48) HPGDALDH1A1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342200-A2 COMPOUNDS WHICH SELECTIVELY MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2011-07-13 EP disclosed
WO-2010036630-A2 COMPOUNDS WHICH SELECTIVELY MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed